CVS targeted by Louisiana AG for unsolicited text messages
The Louisiana Attorney General's Office issued a cease and desist notice to CVS, claiming the retailer had violated the Louisiana Unfair Trade Practices and Consumer Protection Law, R.S. 51:1401.
The AG said it received information that on June 11, 2025, they received information that CVS/Caremark manages the drug plans for thousands of Louisiana citizens and state employees through the Office of Group Benefits, 'improperly appropriated, for its own use, the personal contact information of Louisiana OGB members and other Louisiana customers by sending them unsolicited and unwanted text messages for political reasons.'
Cease-and-Desist-CVS-6.12.2025Download
According to the AG, the information provided in the text messages contained 'inaccurate and deceptive statements' regarding House Bill 358 introduced during the 2025 Regular Session of the Louisiana Legislature as an attempt to urge recipients to contact their representative to oppose the bill, a violation of state law.
AG Murrill advised CVS to end the action, saying that failure to do so may result in the state taking legal action against the retail pharmacy.
The link included in the text message no longer provides information about HB 358.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
16 hours ago
- Bloomberg
Stock Movers: Microsoft, Meta, Ford
On this episode of Stock Movers: - Microsoft (MSFT) shares are soaring in premarket after it reported better-than-expected growth in its cloud business, with its Azure cloud-computing unit posting a 39% rise in sales, handily beating the 34% analysts expected. Microsoft is set to become the second company to reach a $4 trillion market capitalization after reporting quarterly earnings that beat Wall Street's expectations. - Meta (META) are higher this morning after Facebook's parent company gave a strong revenue forecast and reported second-quarter results that beat analysts' expectations. While it also raised its full-year forecast for capital expenditures, analysts said the company's spending was justified by its growth. - Ford (F) is lower after announcing an anticipated full-year net tariff impact of about $2 billion. Ford issued full-year guidance that is lower than its initial forecast over President Trump's tariff policies. Analyst Tom Narayan said potential headwinds include the status of electric vehicle tax credits, softness in Europe, Ford's warranty issue and liquidity. - CVS (CVS) is getting a boost in the premarket after the company boosted its adjusted earnings-per-share guidance for the full year, following second-quarter results that also topped expectations.
Yahoo
17 hours ago
- Yahoo
CVS raises outlook amid solid returns at health care benefits segment
- CVS has once again raised its full-year profit forecast, as the conglomerate said it was boosted by strength at its health care benefits and pharmacy and consumer wellness segments. Under CEO David Joyner, who took over at the helm of the company in October, CVS has been pushing to cut costs and has reshuffled its executive leadership team as it looks to turn around its fortunes following one of the most challenging periods in its six-decade history. In a statement, CVS said it has seen "significant and durable recovery"at its Aetna unit, as well as "growth and momentum" at its pharmacy division. Second-quarter net revenue grew by 8.4% versus a year ago to $98.92 billion, compared to analysts' estimates of $94.61 billion, fueled by better-than-anticipated results at its health care benefits and health services businesses. Adjusted earnings per share operating income edged up by 1.7% to $3.81 billion, while earnings per share came in at $1.81 -- both topping Wall Street projections. Following the returns, CVS said it expects adjusted per-share income to be between $6.30 to $6.40, up from a prior guidance of $6 to $6.20. Cash flow from operations is anticipated to be at least $7.5 billion, versus $7 billion previously. Shares of CVS ripped higher by more than 8% in premarket U.S. trading on Thursday. Related articles CVS raises outlook amid solid returns at health care benefits segment Surge of 50% since our AI selection, this chip giant still has great potential Apollo economist warns: AI bubble now bigger than 1990s tech mania Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 hours ago
- Yahoo
CVS Health tops second quarter expectations and hikes its full-year forecast again
NEW YORK (AP) — CVS Health tops second quarter expectations and hikes its full-year forecast again. Sign in to access your portfolio
